Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

808 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial.
Marchioli R, Marfisi RM, Borrelli G, Chieffo C, Franzosi MG, Levantesi G, Maggioni AP, Nicolosi GL, Scarano M, Silletta MG, Schweiger C, Tavazzi L, Tognoni G. Marchioli R, et al. Among authors: tognoni g. J Cardiovasc Med (Hagerstown). 2007 Sep;8 Suppl 1:S34-7. doi: 10.2459/01.JCM.0000289271.80180.b6. J Cardiovasc Med (Hagerstown). 2007. PMID: 17876196
High pulse pressure and low mean arterial pressure: two predictors of death after a myocardial infarction.
Avanzini F, Alli C, Boccanelli A, Chieffo C, Franzosi MG, Geraci E, Maggioni AP, Marfisi RM, Nicolosi GL, Schweiger C, Tavazzi L, Tognoni G, Valagussa F, Marchioli R; GISSI-Prevenzione investigators. Avanzini F, et al. Among authors: tognoni g. J Hypertens. 2006 Dec;24(12):2377-85. doi: 10.1097/01.hjh.0000251897.40002.bf. J Hypertens. 2006. PMID: 17082719
Coffee consumption and risk of cardiovascular events after acute myocardial infarction: results from the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico)-Prevenzione trial.
Silletta MG, Marfisi R, Levantesi G, Boccanelli A, Chieffo C, Franzosi M, Geraci E, Maggioni AP, Nicolosi G, Schweiger C, Tavazzi L, Tognoni G, Marchioli R; GISSI-Prevenzione Investigators. Silletta MG, et al. Among authors: tognoni g. Circulation. 2007 Dec 18;116(25):2944-51. doi: 10.1161/CIRCULATIONAHA.107.712976. Epub 2007 Dec 3. Circulation. 2007. PMID: 18056527
Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial.
Marchioli R, Levantesi G, Silletta MG, Barlera S, Bernardinangeli M, Carbonieri E, Cosmi F, Franzosi MG, Latini R, Lucci D, Maggioni AP, Moretti L, Nicolosi GL, Porcu M, Rossi MG, Tognoni G, Tavazzi L; GISSI-HF Investigators. Marchioli R, et al. Among authors: tognoni g. Expert Rev Cardiovasc Ther. 2009 Jul;7(7):735-48. doi: 10.1586/erc.09.70. Expert Rev Cardiovasc Ther. 2009. PMID: 19589110
Uric acid: a cardiovascular risk factor in patients with recent myocardial infarction.
Levantesi G, Marfisi RM, Franzosi MG, Maggioni AP, Nicolosi GL, Schweiger C, Silletta MG, Tavazzi L, Tognoni G, Marchioli R. Levantesi G, et al. Among authors: tognoni g. Int J Cardiol. 2013 Jul 15;167(1):262-9. doi: 10.1016/j.ijcard.2011.12.110. Epub 2012 Jan 20. Int J Cardiol. 2013. PMID: 22261690 Clinical Trial.
Plasma n-3 polyunsaturated fatty acids in chronic heart failure in the GISSI-Heart Failure Trial: relation with fish intake, circulating biomarkers, and mortality.
Masson S, Marchioli R, Mozaffarian D, Bernasconi R, Milani V, Dragani L, Tacconi M, Marfisi RM, Borgese L, Cirrincione V, Febo O, Nicolis E, Maggioni AP, Tognoni G, Tavazzi L, Latini R. Masson S, et al. Among authors: tognoni g. Am Heart J. 2013 Feb;165(2):208-15.e4. doi: 10.1016/j.ahj.2012.10.021. Epub 2013 Jan 4. Am Heart J. 2013. PMID: 23351824 Clinical Trial.
A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione scoring.
Macchia A, Levantesi G, Borrelli G, Franzosi MG, Maggioni AP, Marfisi R, Scarano M, Tavazzi L, Tognoni G, Valagussa F, Marchioli R; Associazione Nazionale Medici Cardiologi Ospedalieri; Istituto di Ricerche Farmacologiche Mario Negri-Consorzio Mario Negri Sud, Santa Maria Imbaro; Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione Investigators. Macchia A, et al. Among authors: tognoni g. Am Heart J. 2006 Mar;151(3):754.e7-754.e17. doi: 10.1016/j.ahj.2005.10.023. Am Heart J. 2006. PMID: 16504647
Rationale and design of the GISSI-Atrial Fibrillation Trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence.
Disertori M, Latini R, Maggioni AP, Delise P, Di Pasquale G, Franzosi MG, Staszewsky L, Tognoni G; GISSI-AF Investigators. Disertori M, et al. Among authors: tognoni g. J Cardiovasc Med (Hagerstown). 2006 Jan;7(1):29-38. doi: 10.2459/01.JCM.0000199778.85343.08. J Cardiovasc Med (Hagerstown). 2006. PMID: 16645357 Clinical Trial.
808 results